Drug intelligence / Profile preview

hematein

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical
01

Overview

Hematein is a natural polyphenolic compound and the oxidized derivative of hematoxylin, primarily extracted from the heartwood of logwood (*Haematoxylum campechianum*) or *Caesalpinia sappan*. It is most widely recognized as the active coloring agent in the Hematoxylin and Eosin (H&E) histological stain, where it complexes with metal ions (mordants) to selectively bind and visualize cell nuclei. Beyond its established role as a diagnostic dye and research reagent, hematein has been investigated for potential therapeutic applications due to its multi-target enzyme-inhibiting properties. Research has identified it as a potent inhibitor of IκB kinase β (IKKβ), a key regulator of the NF-κB inflammatory pathway, and as an inhibitor of the Zika virus protease. It also exhibits inhibitory activity against *Cutibacterium acnes* lipase, suggesting potential utility as an anti-acne agent, and acts as a ligand for the chromatin protein barrier-to-autointegration factor 1 (BAF1).

Other names
Oxidized hematoxylinC.I. 75290Natural Black 1
02

Targets

IKBKB (IKKβ)GehA (Cutibacterium acnes triacylglycerol lipase)ZIKV NS2B-NS3pro (Zika virus NS2B-NS3 protease)

Beyond the preview

Go deeper on hematein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hematein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call